TOP STORIES

• BUSINESS Big 4 Wholesalers Suffer 80% Drop in Operating Profit on COVID, Discount, Price Battle: 1H 2020
  November 9, 2020

• ORGANIZATION JPMA Sorts Out Challenges for Remote Clinical Trial to Promote Its Introduction in Japan
  November 9, 2020

• BUSINESS Expert Panel Delivers Harsh Verdict on Aducanumab, FDA Decision Due by March 7
  November 9, 2020

• BUSINESS 1st Half Sales of 7 Major Japan Drug Makers Skid 1.9% on Price Cuts, COVID-19; Core Products Brisk
  November 6, 2020

• BUSINESS In a Digital Push, Takeda Encouraging Sales Reps to Gain IT Qualification: Japan Chief
  November 5, 2020

• REGULATORY Ryukaikon Confab Finally Set for November 24; Can Japan Improve Drug Distribution Environment Again?
  November 4, 2020

• BUSINESS Ex-Merck Serono President Leo Lee Becomes Japan Chief of Novartis
  November 2, 2020

• BUSINESS Emerging from Repeated Price Cuts, Opdivo’s Japan Sales Could Top 100 Billion Yen in FY2020
  October 30, 2020

• REGULATORY Japan to Receive 50 Million Doses of Moderna COVID-19 Vaccines via Takeda
  October 29, 2020

• BUSINESS GSK Might Adjust Shipments for Cervarix as Surge in Demand Expected
  October 29, 2020

• BUSINESS Copay Rose for Some Patients as Leuplin Issue Triggered Shortage of 6-Month Depot: HCPs
  October 28, 2020

• BUSINESS Pharma’s Half-Year Earnings Season in Full Swing from This Week
  October 27, 2020

• BUSINESS Ono Says Honjo’s 22.6 billion Yen Claim Groundless, No Agreement Reached on 40% Opdivo Fee Proposal
  October 27, 2020

• REGULATORY PM Suga Vows to Work towards Annual Price Revisions: Diet Policy Speech
  October 27, 2020

• REGULATORY 1st Working Group Meeting for Prioritization of “Stable Supply Medicines” Set for Early November
  October 26, 2020

• BUSINESS Novartis Looks to Solidify Presence in Multiple Sclerosis Arena with Mayzent, then Ofatumumab
  October 23, 2020

• BUSINESS GSK Sets Up Oncology Biz Unit in Japan; Multiple Late-Stage Assets in Pipeline
  October 22, 2020

• REGULATORY PMDA Sees Studies on Preventive Effect as a “Must” for Coronavirus Vaccines: Official
  October 21, 2020

• BUSINESS Pfizer, BioNTech Begin Japan PI/II Study for COVID-19 Vaccine
  October 21, 2020

• BUSINESS LEO Pharma’s Atopic Dermatitis Program Lags as PMDA Requests Japanese Data, but Growth Goal Intact
  October 20, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 105
• 106
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• …
• Next ›
• 最終 »